Nano-X Imaging Ltd.
$2.15
0%
2026-04-21 08:26:00
www.nanox.vision
NGM: NNOX
Explore Nano-X Imaging Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$181.72 M
Current Price
$2.15
52W High / Low
$5.86 / $2.11
Stock P/E
—
Book Value
$2.4
Dividend Yield
—
ROCE
-28.95%
ROE
-34.75%
Face Value
—
EPS
$-0.88
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
165
Beta
1.38
Debt / Equity
5.03
Current Ratio
4.14
Quick Ratio
5.52
Forward P/E
-7.44
Price / Sales
12.84
Enterprise Value
$111.11 M
EV / EBITDA
-2.42
EV / Revenue
9.03
Rating
None
Target Price
$7.4
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | STERIS plc | $223.73 | 31.17 | $21.95 B | 1.11% | 10.53% | 10.47% | $269.44 / $209.98 | $72.93 |
| 2. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
| 3. | Lucid Diagnostics Inc. | $1.3 | — | $221.18 M | — | -418.44% | -7.11% | $1.7 / $0.95 | $-0.33 |
| 4. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
| 5. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 6. | Sintx Technologies, Inc. | $2.78 | — | $11.46 M | — | -185.71% | -3.04% | $6.78 / $1.72 | $0.74 |
| 7. | Baird Medical Investment Holdings Limited | $1.79 | 55.75 | $64.64 M | — | 35.34% | -8.03% | $7.26 / $0.76 | $1.34 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 3.45 M | 3.04 M | 2.81 M | 3 M | 3.03 M |
| Operating Profit | -14.23 M | -14.49 M | -14.09 M | -14.97 M | -14.14 M |
| Net Profit | -13.68 M | -14.72 M | -13.24 M | -14.06 M | -13.64 M |
| EPS in Rs | -0.2 | -0.21 | -0.19 | -0.2 | -0.2 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 11.28 M | 9.9 M | 8.58 M | 1.3 M |
| Operating Profit | -56.75 M | -59.66 M | -87.21 M | -61.56 M |
| Net Profit | -53.52 M | -60.78 M | -113.24 M | -61.8 M |
| EPS in Rs | -0.77 | -0.87 | -1.63 | -0.89 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 210 M | 218.65 M | 253.93 M | 363.17 M |
| Total Liabilities | 20.88 M | 23.13 M | 37.25 M | 71.02 M |
| Equity | 189.12 M | 195.51 M | 216.68 M | 292.15 M |
| Current Assets | 78.68 M | 88.64 M | 82.46 M | 94.86 M |
| Current Liabilities | 13.97 M | 15.52 M | 25.07 M | 52.75 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -36.6 M | -44.78 M | -43.38 M | -38.06 M |
| Investing CF | -20.05 M | 35.43 M | 14.61 M | -116.32 M |
| Financing CF | 39.5 M | 27.25 M | 0.8 M | 7.38 M |
| Free CF | -39.37 M | -48.08 M | -50.56 M | -61.22 M |
| Capex | -2.77 M | -3.3 M | -7.17 M | -23.16 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.91% | 15.47% | 557.82% | — |
| Earnings Growth % | 11.95% | 46.33% | -83.25% | — |
| Profit Margin % | -474.31% | -613.59% | -1320.16% | -4739.11% |
| Operating Margin % | -502.93% | -602.29% | -1016.65% | -4720.71% |
| Gross Margin % | -94.03% | -66.55% | -80.21% | -115.95% |
| EBITDA Margin % | -398.95% | -483.06% | -882.44% | -4544.94% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.